3 European Projects Found
Searched on 125080 European Projects
FINISHED
Glioma Actively Personalized Vaccine Consortium (GAPVAC)
Start date: Nov 1, 2012, End date: Jan 31, 2017,
"Glioblastoma (GBM) is a rare (2-3 incidences in 100,000) and fatal disease. Each year, approximately 13,000 new cases of GBM are diagnosed in Europe. The 5-year survival rate of this highly aggressive tumor entity under conventional therapy is less than 6%. Currently available therapeutic options neglect the individuality of each patients’ disease and only temporarily influence tumor progression ...
Read Project
13
Partners Participants
FINISHED
Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses (SILVER)
Start date: Oct 1, 2010, End date: Mar 31, 2015,
RNA virus infections kill millions of humans annually, largely due to the lack of suitable vaccines and drugs to control them. This problem is addressed in this FP7 call and in response a consortium of Europe’s and Asia’s leading molecular virologists, structural biologists, medicinal chemists and bioinformaticians has been brought together to generate a state-of-the-art drug discovery and design ...
Read Project
25
Partners Participants
FINISHED
European Training Network on (+)RNA Virus Replication and Antiviral Drug Development (EUVIRNA)
Start date: Mar 1, 2011, End date: Feb 28, 2015,
Virus infections remain a major cause of disease, with dramatic costs in mortality, morbidity, and economic loss worldwide. There is an unmet need for potent antiviral drugs, in particular against viruses with a (+)RNA genome which include many important pathogens of humans and animals.Antiviral drug development requires a detailed understanding of virus replication and effective translation of th ...
Read Project
